Cited by 53Neuroendocrine regulation and behaviorGenetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Oxytocin as a Modulator of Synaptic Plasticity: Implications for Neurodevelopmental Disorders

Open access
Rajamani, Keerthi Thirtamara, Wagner, Shlomo, Grinevich, Valery, Harony-Nicolas, Hala·2018·Frontiers in Synaptic Neuroscience

Abstract

The neuropeptide oxytocin is a crucial mediator of parturition and milk ejection and a major modulator of various social behaviors, including social recognition, aggression and parenting. In the past decade, there has been significant excitement around the possible use of oxytocin to treat behavioral deficits in neurodevelopmental disorders, including autism spectrum disorder (ASD). Yet, despite the fast move to clinical trials with oxytocin, little attention has been paid to the possibility that the oxytocin system in the brain is perturbed in these disorders and to what extent such perturbations may contribute to social behavior deficits. Large-scale whole-exome sequencing studies in subjects with ASD, along with biochemical and electrophysiological studies in animal models of the disorder, indicate several risk genes that play an essential role in brain synapses, suggesting that deficits in synaptic activity and plasticity underlie the pathophysiology in a considerable portion of these cases. Oxytocin has been repeatedly shown, both in vitro and in vivo, to modify synaptic properties and plasticity and to modulate neural activity in circuits that regulate social behavior. Together, these findings led us to hypothesize that failure of the oxytocin system during early development, as a direct or indirect consequence of genetic mutations, may impact social behavior by altering synaptic activity and plasticity. In this paper, we review the evidence that support our hypothesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnsyn.2018.00017

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Oxytocin-enhanced therapy would have the combined benefits of increasing the salience of information coming from the therapist, promoting synaptic plasticity, and facilitating learning by modulating circuit-level neural activity.

    “Oxytocin-enhanced therapy would have the combined benefits of increasing the salience of information coming from the therapist [63,64], promoting synaptic plasticity [65], and facilitating learning by modulating circuit-level neural activity [37*,66].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rajamani, K. T., Wagner, S., Grinevich, V., & Harony-Nicolas, H.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • University of Haifa (IL)
  • German Cancer Research Center (DE)
Venue
Frontiers in Synaptic Neuroscience
Published
2018-06-19
Volume
10
Pages
17-17
ISSN
1663-3563 (ISSN-L)
OpenAlex
W2806224492
Cited by
53
References
21
Citations by year
2026: 4 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 11 · 2021: 7 · 2020: 7 · 2019: 6
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Synaptic Neuroscience (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Human Frontier Science Program (RGP0019/2015)
  • Israel Science Foundation (1361/17)
  • Deutsche Forschungsgemeinschaft (GR 3619/4-1)
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
oxytocin, synaptic plasticity, neurodevelopmental disorders, autism spectrum disorder, social behavior deficits, oxytocinergic system, risk genes, genetic mutations, social recognition, aggression, parental behavior, oxytocin therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review